Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lucien Perey"'
Autor:
Dorothea Wunder, Lucien Perey
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 3940 (2012)
Due to constant progress in oncology, survival rates of patients (children and adults) with cancer are increasing. Consequently, the reproductive future of young cancer patients needs to be addressed carefully. Fertility preservation techniques are a
Externí odkaz:
https://doaj.org/article/62b2f45a6a484627822089c0b7483bb5
Autor:
Yves Chalandon, Smaranda Gazdaru, Nicolas Vulliemoz, Anne Rosselet, Patrice Mathevet, Lucien Perey
Publikováno v:
The Oncologist, Vol. 23, No 6 (2018) pp. 719-721
The development of tyrosine-kinase inhibitors (TKIs) has improved survival of patients with chronic myeloid leukemia (CML). Some patients may become resistant to TKIs and require hematopoietic stem cell transplant (HSCT) that is highly gonadotoxic. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613b9bb06b68ad294c5ab505e95913a0
https://doi.org/10.1634/theoncologist.2017-0381
https://doi.org/10.1634/theoncologist.2017-0381
Autor:
U Hasler-Strub, Patrick Neven, Khalil Zaman, Christoph Mamot, Hanne Hawle, Christine Biaggi Rudolf, Christoph Rochlitz, Hans Wiliders, Ralph Winterhalder, Andreas Mueller, Catherine Berset, Lucien Perey, Stephanie Rondeau
Publikováno v:
European Journal of Cancer. 51:1212-1220
Background Second line endocrine therapy has limited antitumour activity. Fulvestrant inhibits and downregulates the oestrogen receptor. The mitogen-activated protein kinase (MAPK) pathway is one of the major cascades involved in resistance to endocr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3243150cbfb7657dfecf2c53539af63d
https://doi.org/10.1016/j.ejca.2015.03.016
https://doi.org/10.1016/j.ejca.2015.03.016
Autor:
Ralph Winterhalder, Lucien Perey, Catherine Berset, C Biaggi Rudolf, Christoph Mamot, Patrick Neven, Stephanie Rondeau, Andreas Mueller, H Wiliders, Christoph Rochlitz, U Hasler-Strub, Khalil Zaman
Publikováno v:
Cancer Research. 73:P2-16
Background: Mitogen-activated protein kinase (MAPK) pathway is one of the major signaling cascades responsible for resistance to endocrine therapy by promoting estrogen-independent tumor growth. Sel is a potent selective MEK1 and MEK2 inhibitor activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95d34ff1a732e9cfe1a6c1389067516d
https://doi.org/10.1158/0008-5472.sabcs13-p2-16-19
https://doi.org/10.1158/0008-5472.sabcs13-p2-16-19
Autor:
Lucien Perey
Le soir arrivé, les enfants tout joyeux reprennent leurs places accoutumées. JAVOTTE. Quel bonheur que vous soyez revenue, grand'mère, et quel bonheur que vous ayez retrouvé votre conte ; car il est retrouvé, n'est-ce pas? GRAND'MÈRE, souriant.
Publikováno v:
Revue medicale suisse. 12(519)
While mutations in BRCA1 and BRCA2 are found in only a minority of breast cancer patients, their impact for those patients is important. It is a powerful risk factor for this disease with respectively 65% and 45% of the women developing breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fca507e6da3511669df6b54b6a6590bf
https://pubmed.ncbi.nlm.nih.gov/27424423
https://pubmed.ncbi.nlm.nih.gov/27424423
Autor:
S. Stiefel, Serge Leyvraz, J. Bauer, P. F. Leyvraz, A. Bressoud, Pasquale Mordasini, O. Real del Sarte, Lucien Perey
Publikováno v:
Supportive Care in Cancer, vol. 15, no. 5, pp. 525-531
Bressoud, A; Real del Sarte, O; Stiefel, S; Mordasini, P; Perey, L; Bauer, J; Leyvraz, P F; Leyvraz, S (2007). Impact of family structure on long-term survivors of osteosarcoma. Supportive care in cancer, 15(5), pp. 525-31. Berlin: Springer 10.1007/s00520-006-0196-5
Bressoud, A; Real del Sarte, O; Stiefel, S; Mordasini, P; Perey, L; Bauer, J; Leyvraz, P F; Leyvraz, S (2007). Impact of family structure on long-term survivors of osteosarcoma. Supportive care in cancer, 15(5), pp. 525-31. Berlin: Springer 10.1007/s00520-006-0196-5
GOALS OF WORK: Long-term outcomes of osteosarcoma have dramatically improved with the use of modern combination therapies. Such aggressive treatments, however, entail chronic complications. In the present study, we assessed the functional, psychologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dfe38f37c06163ef11bb9f3623bde76
https://doi.org/10.1007/s00520-006-0196-5
https://doi.org/10.1007/s00520-006-0196-5
Autor:
A. Goldhirsch, Richard D. Gelber, Andrea Veronesi, John F. Forbes, Beat Thürlimann, Carl Magnus Rudenstam, David Zahrieh, John P. Collins, Alan S. Coates, Diana Crivellari, Elizabeth Murray, Juerg Bernhard, Raymond Snyder, K. N. Price, M. Castiglione-Gertsch, C. Hürny, Martin F. Fey, Lucien Perey
Publikováno v:
British Journal of Cancer
We evaluated quality of life (QL) and quality-adjusted survival in International Breast Cancer Study Group Trial IX, a randomised trial including 1669 eligible patients receiving tamoxifen for 5 years or three prior cycles of cyclophosphamide, methot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b07efe85667aac33ed11f6c9dc082b6
https://doi.org/10.1038/sj.bjc.6602230
https://doi.org/10.1038/sj.bjc.6602230
Autor:
Nicolas Ketterer, J. Bauer, Roger Stupp, Mohamed Bakr, Bertrand Duvoisin, Lucien Perey, Serge Leyvraz, Alexandre Bodmer
Publikováno v:
Oncology. 61:35-41
Platinum-based chemotherapy is considered standard treatment for advanced non-small-cell lung cancer (NSCLC). However, toxicity of most platinum-based regimens is substantial and requires close monitoring and supportive care. Over the past decade, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de814a1cc4ec453d54687589fdf659ab
https://doi.org/10.1159/000055390
https://doi.org/10.1159/000055390
Autor:
Aron Goldhirsch, Hervé Bonnefoi, Lucien Perey, Jürg Bernhard, Monica Castiglione, Beat Thürlimann, Marisa Bacchi, C. Hürny, Marzio E E Sabbioni, Hans Peter Siegrist, Hans-Jörg Senn
Publikováno v:
Supportive Care in Cancer. 7:149-153
The effects and interaction of endocrine and cytotoxic adjuvant treatment on measures of cellular immunity were assessed in 41 stage I-II breast cancer patients from International Breast Cancer Study Group trials. Counts of lymphocytes and lymphocyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68fa6d21b1d55c406c5e1d9806e2cc2d
https://doi.org/10.1007/s005200050245
https://doi.org/10.1007/s005200050245